Jul 16, 2026 · 1h 47m
Leading researcher argues cancer is a metabolic disease of the mitochondria
Leading Cancer Researcher: They’re Ignoring My Research, Cancer Patients Must Know This!
Reframing cancer as a metabolic disease opens up accessible, lifestyle-based prevention strategies and helper therapies that target how tumor cells generate energy.
- 1Cancer cells rely on ancient fermentation pathways fueled by glucose and glutamine to survive when mitochondria are damaged.
- 2The Glucose Ketone Index serves as a vital biomarker tool to measure and monitor overall mitochondrial health.
- 3Nutritional ketosis and fasting-mimicking diets can selectively starve tumor cells while protecting healthy tissue.
Don't miss
Steven Bartlett tests his own Glucose Ketone Index live on the show to demonstrate how to calculate the ratio using a ketone-glucose reader.
The brief
Dr. Thomas Seyfried challenges mainstream oncology by arguing that cancer is primarily a mitochondrial metabolic disease rather than a genetic one, tracing this science back to Otto Warburg's early 20th-century discoveries.
When mitochondria are damaged by modern lifestyle factors like ultra-processed foods and chronic stress, cells revert to ancient fermentation pathways, feeding greedily on glucose and glutamine to survive and multiply.
By shifting from carbohydrate fuel to lipid ketone fuel, individuals can use the Glucose Ketone Index as a biomarker to monitor their mitochondrial health and enter a zone of prevention against chronic diseases.
Implementing metabolic therapies like nutritional ketosis, fasting, and hyperbaric oxygen therapy can selectively stress and starve tumor cells, protecting healthy tissue and enhancing standard cancer treatments.
Featuring
cancer
Otto Heinrich Warburg
Glucose
GlutamineBooks & mentions
The Diary Of A CEO with Steven Bartlett
Explore more deep-dive health and science conversations with leading global experts.
Listen to the full episode and explore every guest, topic, and moment on PodLume.